Exact Sciences

Exact Sciences, focused on the early detection and prevention of colorectal cancer. Read more

202 Followers on Owler
202 Followers on Owler
202 Followers on Owler
202 Followers on Owler

Exact Sciences

Exact Sciences, focused on the early detection and prevention of colorectal cancer. Read more

Kevin T. Conroy's photo - Chairman & CEO of Exact Sciences

Chairman & CEO

Kevin T. Conroy

CEO Approval Rating

94/100

Founded:

1995

Status:

PublicIndependent CompanyNASDAQEXAS

EXACT SCIENCES TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Polymedco is the top competitor of Exact Sciences. Polymedco is headquartered in Cortlandt Manor, New York, and was founded in 1980. Polymedco competes in the Health Care Equipment field. Polymedco generates 2.17% the revenue of Exact Sciences.

Genomic Expression is perceived as one of Exact Sciences's biggest rivals. Genomic Expression was founded in Beverly, Massachusetts} in 2009. Genomic Expression operates in the Biotechnology industry. Compared to Exact Sciences, Genomic Expression generates $1.5B less revenue.

Trusted Tablets is seen as one of Exact Sciences's top competitors. Trusted Tablets is a Private company that was founded in Larnaca, Larnarca District in 2007. Trusted Tablets competes in the Pharmaceuticals industry. Trusted Tablets has 1,653 fewer employees vs. Exact Sciences.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Hemosure a competitor of Exact Sciences?

Exact Sciences Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$1.5B

Exact Sciences's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 381.4M. Over the last four quarters, Exact Sciences's revenue has grown by 49.5%. Specifically, in Q1 2021's revenue was $402.1M; in Q4 2020, it was $466.3M; in Q3 2020, it was $408.4M; in Q2 2020, Exact Sciences's revenue was $268.9M.

Exact Sciences Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
PFS Genomics, Inc.

May 2021

Source »
$30.6M
PFS Genomics is a New York-based biotechnology company that researches and develops personalized radiotherapy for the treatment of breast cancer diseases.
Ashion Analytics, LLC

Feb 2021

Source »
undisclosed
Ashion is a biotechnology firm that provides clinical genomics testing and RNA sequencing services for diagnosing cancer.
Thrive Earlier Detection Corp.

Oct 2020

Source »
$2.1B
Thrive develops a liquid biopsy-based testing platform that offers early-stage cancer detection solutions to physicians.
Base Genomics

Oct 2020

Source »
$410M
Base Genomics is an epigenetics company that develops DNA methylation analytics platform for the detection of early-stage cancers.
Paradigm Diagnostics, Inc.

Mar 2020

Source »
undisclosed
Paradigm Diagnostics is a precision medicine company that provides genetic and molecular testing services for the treatment of cancer.

These are all the companies that Exact Sciences has acquired. Exact Sciences has acquired 9 companies and its latest acquisition was PFS Genomics, Inc. in May 2021. PFS Genomics is a New York-based biotechnology company that researches and develops personalized radiotherapy for the treatment of breast cancer diseases.

Exact Sciences Funding History

Since Exact Sciences was founded in 1995, it has participated in 2 rounds of funding. In total Exact Sciences has raised $64.2M. Exact Sciences' last funding round was on Jun 2009 for a total of $8.2M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jun 2009
$8.2M
-
IPO
Jan 2001
$56M

Since Exact Sciences was founded in 1995, it has participated in 2 rounds of funding. In total Exact Sciences has raised $64.2M. Exact Sciences' last funding round was on Jun 2009 for a total of $8.2M

Exact Sciences Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

SU2C is a California-based non-profit organization that raises funds for cancer treatment research through online and televised efforts.
$10M
Dec 31, 2020
Grant
-
Thrive develops a liquid biopsy-based testing platform that offers early-stage cancer detection solutions to physicians.
$110M
May 29, 2019
Series A
-

These are all the companies that Exact Sciences has invested in. Exact Sciences has invested 9 companies and its latest investment was PFS Genomics, Inc. in May 2021. PFS Genomics is a New York-based biotechnology company that researches and develops personalized radiotherapy for the treatment of breast cancer diseases.

Exact Sciences News

April 8, 2021BioSpace

Exact Sciences schedules first quarter 2021 earnings call

Exact Sciences Corp. announced that the company plans to release its first quarter 2021 financial res... See more »
April 1, 2021MarketScreener

New NCCN Breast Cancer Guidelines Recognize Oncotype DX Breast Recurrence Score Test

(marketscreener.com) New NCCN Breast Cancer Guidelines Recognize Oncotype DX Breast Recurrence Score®... See more »
March 23, 2021FiercePharma

Exact Sciences, Stand Up to Cancer and Jamie Foxx team up to drive colorectal screenings

Exact Sciences, Stand Up to Cancer and Jamie Foxx team up to drive colorectal screenings bbulik Tue, ... See more »
February 22, 2021MarketScreener

Exact Sciences to participate in March investor conferences

(marketscreener.com) MADISON, Wis., Feb. 22, 2021 /PRNewswire/ -- Exact Sciences Corp. today announce... See more »

Exact Sciences Blogs

Exact Sciences Press Releases

January 13, 2021StreetInsider

New Prospective Data Demonstrate Low False-Positive Rate for Screening Average-Risk People Age 45-49 for Colorectal Cancer with Cologuard

MADISON, Wis., Jan. 12, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) announced...... See more »
December 11, 2020PR Newswire

New Data at SABCS 2020 Highlight the Role of the Oncotype DX Breast Recurrence Score Test in Shaping Clinical Practice

MADISON, Wis., Dec. 11, 2020 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced the ... See more »
December 9, 2020PR Newswire Asia

RxPONDER Study Results Demonstrate that the Oncotype DX Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer

- First results from the independent SWOG Cancer Research Network-led Phase III study to be presented... See more »
November 2, 2020PR Newswire

Exact Sciences to participate in November investor conferences

MADISON, Wis., Nov. 2, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that ... See more »
October 29, 2020StreetInsider

Update on the partnership with Exact Sciences

PRESS RELEASE: REGULATORY INFORMATION INSIDE INFORMATION 29 October 2020, 08:30 CET Update on the par... See more »
October 14, 2020StreetInsider

Exact Sciences Selects Veeva Vault Clinical Suite to Help Accelerate Innovation

Leading medical diagnostics company unifies clinical data management and operations for increased eff... See more »
October 12, 2020PR Newswire

Exact Sciences Introduces the Oncotype MAP Pan-Cancer Tissue Test to Help Guide Treatment for Patients with Advanced Cancer

MADISON, Wis., Oct. 12, 2020 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced the ... See more »

Exact Sciences Videos

Social Media

Exact Sciences Headquarters

441 Charmany Drive

Madison, Wisconsin53719

608-284-5700

Driving Directions »

Trending Companies

Exact Sciences Summary

ABOUT

Overview

Exact Sciences, focused on the early detection and prevention of colorectal cancer. Exact Sciences was founded in 1995. Exact Sciences' headquarters is located in Madison, Wisconsin, USA 53719. It has raised 64.2M in 2 rounds. The latest round was in ...

CEO

Exact Sciences's Chairman & CEO, Kevin T. Conroy, currently has an approval rating of 94%. Exact Sciences's primary competitors are Polymedco, Genomic Expression & Trusted Tablets.

Website

exactsciences.com

Frequently Asked Questions about Exact Sciences

  1. When was Exact Sciences founded?

    Exact Sciences was founded in 1995
  2. Who is Exact Sciences's CEO?

    Exact Sciences's CEO is Kevin T. Conroy
  3. How much revenue does Exact Sciences generate?

    Exact Sciences generates $1.5B in revenue
  4. How much funding does Exact Sciences have?

    Exact Sciences has historically raised $64.2M in funding
  5. Where is Exact Sciences's headquarters?

    Exact Sciences's headquarters is in Madison Wisconsin, USA
  1. How many employees does Exact Sciences have?

    Exact Sciences has 1,977 employees
  2. What sector does Exact Sciences operate in?

    Exact Sciences is in Health Care Services
  3. Who are Exact Sciences's competitors?

    Exact Sciences's top competitors are Polymedco, Genomic Expression, Trusted Tablets
  4. Who has Exact Sciences invested in?

    Exact Sciences's has invested in companies such as SU2C, Thrive